Apolipoprotein E ε4 (APOE ε4) is a well-known risk factor affecting the likelihood and age of onset of Alzheimer’s disease (AD) [6–12], with a dose dependence characteristic (i. e., two alleles are associated with an increased risk compared to one) [12,13]. This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.